BRUKER CORPORATION Payments to Acquire Marketable Securities
BRUKER CORPORATION (BRKR) reported Payments to Acquire Marketable Securities of $118.50 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2018-03-16
- BRUKER CORPORATION payments to acquire marketable securities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION payments to acquire marketable securities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION payments to acquire marketable securities for the quarter ending 2017-06-30 was $33.20M, a 191.23% increase year-over-year.
- BRUKER CORPORATION payments to acquire marketable securities for the quarter ending 2017-03-31 was $85.30M, a 293.09% increase year-over-year.
- BRUKER CORPORATION payments to acquire marketable securities for fiscal 2017 was $118.50M, a 6.32% decline from fiscal 2016.
- BRUKER CORPORATION payments to acquire marketable securities for fiscal 2016 was $126.50M, a 20.64% decline from fiscal 2015.
- BRUKER CORPORATION payments to acquire marketable securities for fiscal 2015 was $159.40M, a 24.67% decline from fiscal 2014.
- BRUKER CORPORATION payments to acquire marketable securities for fiscal 2014 was $211.60M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 3 month as first filed | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $33.20M derived: sum of 3 quarters · filed 2018-03-16 | $118.50M 10-K · filed 2018-03-16 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $33.20M derived: sum of 2 quarters · filed 2017-11-09 | $118.50M 10-Q · filed 2017-11-09 | $167.40M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2017-06-30 | $33.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $118.50M 10-Q · filed 2017-08-09 | $167.40M derived: sum of 3 quarters · filed 2018-03-16 | $211.90M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2017-03-31 | $85.30M 10-Q · filed 2017-05-10 | $134.20M derived: sum of 2 quarters · filed 2018-03-16 | $178.70M derived: sum of 3 quarters · filed 2018-03-16 | $190.10M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-12-31 | $48.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $93.40M derived: sum of 2 quarters · filed 2018-03-16 | $104.80M derived: sum of 3 quarters · filed 2018-03-16 | $126.50M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $44.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $55.90M derived: sum of 2 quarters · filed 2017-11-09 | $77.60M 10-Q · filed 2017-11-09 | $159.00M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $11.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $33.10M 10-Q · filed 2017-08-09 | $114.50M derived: sum of 3 quarters · filed 2018-03-16 | $143.40M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $21.70M 10-Q · filed 2017-05-10 | $103.10M derived: sum of 2 quarters · filed 2018-03-16 | $132.00M derived: sum of 3 quarters · filed 2018-03-16 | $159.60M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $81.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $110.30M derived: sum of 2 quarters · filed 2018-03-16 | $137.90M derived: sum of 3 quarters · filed 2018-03-16 | $159.40M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $28.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $56.50M derived: sum of 2 quarters · filed 2016-11-09 | $78.00M 10-Q · filed 2016-11-09 | $168.80M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $27.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $49.10M 10-Q · filed 2016-08-05 | $139.90M derived: sum of 3 quarters · filed 2017-03-01 | $192.90M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $21.50M 10-Q · filed 2016-05-06 | -$21.50M 10-Q · filed 2015-05-08 | $112.30M derived: sum of 2 quarters · filed 2017-03-01 | $165.30M derived: sum of 3 quarters · filed 2017-03-01 | |
| 2014-12-31 | $90.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $143.80M derived: sum of 2 quarters · filed 2017-03-01 | $211.60M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $120.80M 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | $67.80M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |